Autoimmune events during interferon beta-1b treatment for multiple sclerosis
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 162 (1) , 74-83
- https://doi.org/10.1016/s0022-510x(98)00299-8
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapyHepatology, 1997
- Long term recombinant interferon alpha treatment in MS with special emphasis to side effectsMultiple Sclerosis Journal, 1996
- Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1bNeurology, 1995
- Frequency of anti‐nuclear antibodies in multiple sclerosisNeurology, 1995
- Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosisNeurology, 1994
- Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain.Proceedings of the National Academy of Sciences, 1990
- Autoimmunity in multiple sclerosisNeurology, 1988
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986
- Antinuclear Antibodies in Multiple SclerosisArchives of Neurology, 1982